Genomic cancer testing can be a crucial step in a patient’s diagnosis and may identify how tumors behave and grow. Genomic cancer tests can identify DNA alterations regardless of a tumor's location in the body. Painting the full picture is the first step in building a treatment plan. Learn more about genomic testing. | Bayer U.S.

10+ different types of genomic alterations (or biomarkers) – changes within cancer cells that can determine how the tumor behaves and why it grows – can be found in non-small cell lung cancer including: NTRK*, KRAS, EGFR, ALK, HER2, BRAF, PIK3CA, ROS1, RET, MET, AKT1, NRAS, MAPP2K1. Learn more about how genomic cancer testing may open new doors to treatment options. 溺 *Neurotrophic tyrosine receptor kinase | Bayer U.S. | Facebook

12 reactions | Unlike a genetic test, which assesses hereditary risk for cancer, a genomic test looks at cancer tissue to provide information on how a specific tumor might behave. When a doctor orders genomic biomarker testing, they’re actually looking into the patient's tumor's unique biology to reveal the most appropriate treatment options. | Until Everyone Knows | Facebook